Paola Barbarino appointed as new CEO

29 March 2017 - We are excited to announce that Paola Barbarino has been appointed as our new CEO. Paola will assume the role on 15 May 2017, after which there will be a period of transition alongside outgoing Executive Director, Marc Wortmann. [read more]

ADI and DAI represented at 17th session of CRPD Committee

20 March 2017 – Phyllis Fehr, Board Member of Dementia Alliance International (DAI) and Vice Chair of the Ontario Dementia Advisory Group, will call for greater recognition of dementia on the first day of the 17th session of the United Nations Committee on the Convention on the Rights of Persons with Disabilities (CRPD) today in Geneva. [read more]

Women carry weight of global dementia crisis

08 March 2017 - A new report released today by Global Alzheimer’s and Dementia Action Alliance (GADAA) shows the disproportionate effect of dementia on women everywhere. Women & Dementia: A Global Challenge shows that while women are more likely to develop dementia, they account for the majority of primary care partners around the world and are more likely to have to change to their employment status to provide care for those living with the condition. [read more]

WHO progress Global plan on dementia

30 January 2017 - The Executive Board of the World Health Organization (WHO) has recommended that the draft Global plan on the public health response to dementia 2017-2025 be put before all WHO Member States at the World Health Assembly in May. The decision was made after a statement was delivered by ADI at the 140th session of the Board in Geneva. [read more]

A look back at 2016

19 December 2016 - 2016 was another busy year for Alzheimer's Disease International (ADI), as we continued to work alongside Alzheimer associations worldwide to make dementia a global health priority. These achievements support our vision of prevention, care and inclusion today, and cure tomorrow. [read more]

Alzheimer community between disappointment and hope at CTAD conference 2016

18 December 2016 - Almost 50 million people worldwide now have dementia, and there have been no new drugs approved for the treatment of Alzheimer’s since 2003. The International Congress on Clinical Trials for Alzheimer’s Disease (CTAD) is always a good place to get an overview of what is in the pipeline and the 9th CTAD took place last week in the city of San Diego, USA. [read the full blog]

Global Perspective Newsletter for December 2016

The December 2016 issue of our Global Perspective newsletter is now available. This issue includes the launch of the World Alzheimer Report 2016 and regular features and contributions from Alzheimer associations around the world. [Read it now]

UN Open-Ended Working Group on the Rights of Older Persons

12 December 2016 - Alzheimer's Disease International will make the following statement to the United Nations (UN) Open-Ended Working Group on the Rights of Older Persons in New York, USA today. [read more]

UN International Day of Persons with Disabilities

3 December 2016 - Alzheimer’s Disease International (ADI) and Dementia Alliance International (DAI) are calling on governments around the world to recognise the growing impact of dementia on the United Nations (UN) International Day of Persons with Disabilities. [read more]

ADI responds to results of EXPEDITION3 study by Eli Lilly

23 November 2016 - Alzheimer’s Disease International (ADI) has noted the announcement of Phase 3 clinical trial results today that suggest negative results of the drug solanezumab by Eli Lilly. [read more]